Cellular Biomedicine Group, Inc. (CBMG) financial statements (2021 and earlier)

Company profile

Business Address 209 PERRY PARKWAY
GAITHERSBURG, MD 20877
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 155322391515
Cash and cash equivalents 155322391515
Restricted cash and investments 17     
Receivables  00010
Inventory, net of allowances, customer advances and progress billings     00
Inventory     00
Intangible current assets      11
Other current assets      0
Other undisclosed current assets 22311(10)
Total current assets: 345525411716
Noncurrent Assets
Operating lease, right-of-use asset 20
Property, plant and equipment 211513431
Long-term investments and receivables 000157
Long-term investments 000157
Intangible assets, net (including goodwill) 8888819
Goodwill 888888
Intangible assets, net (excluding goodwill)      11
Other undisclosed noncurrent assets 14141616171
Total noncurrent assets: 633737283328
TOTAL ASSETS: 979261694944
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 421113
Accounts payable 200000
Accrued liabilities 221112
Taxes payable 0000 1
Debt 14     
Due to related parties      0
Other liabilities 542121
Total current liabilities: 2464234
Noncurrent Liabilities
Liabilities, other than long-term debt 1800000
Accounts payable and accrued liabilities  00000
Other liabilities 18     
Total noncurrent liabilities: 1800000
Total liabilities: 4264335
Stockholders' equity
Stockholders' equity attributable to parent 568557664639
Common stock 000000
Treasury stock, value (15)(14)(4)   
Additional paid in capital 27225117315310475
Accumulated other comprehensive income (loss) (1)(1)(0)(1)(0)2
Accumulated deficit (200)(150)(111)(86)(57)(38)
Total stockholders' equity: 568557664639
TOTAL LIABILITIES AND EQUITY: 979261694944

Income statement (P&L) ($ in millions)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues 002131
Revenue, net0131
Operating lease, lease income 3
Other income 112  
Cost of revenue (0)(0)(0)(1)(2)(0)
Cost of goods and services sold   (0)(1)(2)(0)
Other undisclosed gross profit   (2)(0)0 
Gross profit: 000(0)10
Operating expenses (51)(41)(28)(29)(23)(13)
Other undisclosed operating income 000120
Operating loss: (51)(41)(28)(28)(21)(12)
Nonoperating income 122010
Other nonoperating income 012010
Interest and debt expense (0)     
Loss from continuing operations before equity method investments, income taxes: (50)(39)(25)(28)(20)(12)
Other undisclosed income from continuing operations before income taxes 0     
Loss from continuing operations before income taxes: (50)(39)(25)(28)(20)(12)
Income tax expense (benefit) (0)(0)(0)0(1)(0)
Loss from continuing operations: (50)(39)(25)(28)(21)(12)
Loss from discontinued operations      (3)
Net loss: (50)(39)(25)(28)(21)(16)
Other undisclosed net income (loss) attributable to parent    (0)10
Net loss available to common stockholders, diluted: (50)(39)(25)(28)(19)(15)

Comprehensive Income ($ in millions)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss: (50)(39)(25)(28)(21)(16)
Other comprehensive income (loss) 0(1)1(1)(0)0
Comprehensive loss: (50)(40)(25)(29)(21)(16)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent   (0)(0)02
Comprehensive loss, net of tax, attributable to parent: (50)(40)(25)(29)(21)(14)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: